- Home
- BGLC vs BMRA Comparison
BGLC vs BMRA Comparison
Compare BGLC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- BMRA
- Stock Information
- Founded
- BGLC 2017
- BMRA 1971
- Country
- BGLC Malaysia
- BMRA United States
- Employees
- BGLC N/A
- BMRA N/A
- Industry
- BGLC Medical Specialities
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BGLC Health Care
- BMRA Health Care
- Exchange
- BGLC Nasdaq
- BMRA Nasdaq
- Market Cap
- BGLC 7.6M
- BMRA 7.4M
- IPO Year
- BGLC N/A
- BMRA N/A
- Fundamental
- Price
- BGLC $0.37
- BMRA $0.33
- Analyst Decision
- BGLC
- BMRA
- Analyst Count
- BGLC 0
- BMRA 0
- Target Price
- BGLC N/A
- BMRA N/A
- AVG Volume (30 Days)
- BGLC 117.9K
- BMRA 68.2K
- Earning Date
- BGLC 11-20-2024
- BMRA 10-15-2024
- Dividend Yield
- BGLC N/A
- BMRA N/A
- EPS Growth
- BGLC N/A
- BMRA N/A
- EPS
- BGLC N/A
- BMRA N/A
- Revenue
- BGLC $9,183,168.00
- BMRA $5,509,000.00
- Revenue This Year
- BGLC N/A
- BMRA N/A
- Revenue Next Year
- BGLC N/A
- BMRA N/A
- P/E Ratio
- BGLC N/A
- BMRA N/A
- Revenue Growth
- BGLC N/A
- BMRA 1.74
- 52 Week Low
- BGLC $0.31
- BMRA $0.24
- 52 Week High
- BGLC $3.39
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- BMRA 47.85
- Support Level
- BGLC $0.38
- BMRA $0.28
- Resistance Level
- BGLC $0.49
- BMRA $0.35
- Average True Range (ATR)
- BGLC 0.02
- BMRA 0.04
- MACD
- BGLC -0.01
- BMRA 0.00
- Stochastic Oscillator
- BGLC 5.94
- BMRA 41.67
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.